mdlinx mdlinx
Oncology Articles on MDLinx
Latest (44) Full Text Top Read since last login Focus on Head & neck Article Summary

Sentinel lymph node biopsy is unsuitable for routine practice in younger female patients with unilateral low-risk papillary thyroid carcinoma Full Text
BMC Cancer, 09/09/2011

Huang Q et al. – Compared to a single technique, there was a significantly higher SLN identification rate for the combined technique in younger female with ipsilateral, low–risk PTC (T1–2N0M0). Thus, a combined SLN biopsy technique seems to more accurately stage lymph nodes, with better identification of SLN located out of the central compartment. Regardless of the procedure used, the high FNR renders the current SLN techniques unsuitable for routine practice. Based on these results, prophylactic node dissection of level VI might be considered because 38.1% of the patients had such node metastases.

Methods

  • From January 2004 to January 2007, 90 female patients, ages 23 to 44 (mean = 35), with unilateral low–risk PTC (T1–2N0M0) were prospectively studied
  • Mean tumor size was 1.3 cm (range, 0.8–3.7cm). All patients underwent unilateral modified neck dissection
  • Prior to surgery, patients had, by random assignment, identification and biopsy of SLNs by methylene blue, alone (Group 1), or by sulfur colloid labeled with 99m Technetium, gamma–probe guided surgery and methylene blue (Group 2)

Results

  • In the methylene blue group, SLNs were identified in 39 of 45 patients (86.7%)
  • Of 39 patients, 28 (71.8%) had positive cervical lymph nodes (pN+), and 21 patients (53.8%) had pSLN+
  • In 7 of 28 pN+ patients (25%), metastases were also detected in non–SLN, thus giving a false–negative rate (FNR of 38.9% (7/18), negative predictive value (NPV) of 61.1% (11/18), and an accuracy of 82.1% (32/39)
  • In the combined technique group, the identification rate (IR) of SLN was 100% (45/45)
  • Of 45 patients, 27 (60.0%) had pN+, 24 (53.3%) had pSLN+
  • FNR of 14.3% (3/21), a NPV of 85.7% (18/21), and an accuracy of 93.3% (42/45)
  • Combined techniques group was significantly superior to methylene blue group in IR (p=0.035)
  • No significant differences between 2 groups in sensitivity, specificity, NPV, or accuracy
  • Location of pN+ (55 patients) in 84 patients was: level I and V, no patients; level II, 1 patient (1.2%); level III, 6 patients (7.2%); level III and IV, 8 patients (9.5%); level IV, alone, 8 patients (9.5%); level VI, 32 patients (38.1%)
  • In all 90 patients, IR of SLN was 93.3%, FNR, 25.6%, NPV, 74.4%, and accuracy rate, 88.1 percent

Read this article in BMC Cancer read MDLinx article: Sentinel lymph node biopsy is unsuitable for routine practice in younger female patients with unilateral low-risk papillary thyroid carcinoma

<< Previous Article | Next Article >>
Showing Latest Articles
Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Oncology Articles

Last month's top read Top 50 of 2011

1 Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP Protocol B-24 Journal of Clinical Oncology, April 9, 2012    Clinical Article

2 The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal Full Text Journal of Gastrointestinal Oncology, April 16, 2012    Free full text    Clinical Article

3 Preoperative chemotherapy plus trastuzumab, lapatinib, or both in human epidermal growth factor receptor 2-positive operable breast cancer: Results of the randomized phase III CHER-LB study Journal of Clinical Oncology, April 12, 2012    Clinical Article

4 Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancer European Journal of Cancer, April 2, 2012    Clinical Article

5 Metformin use is associated with better survival of diabetic patients with pancreatic cancer Clinical Cancer Research, April 4, 2012    Clinical Article

6 Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study The Lancet, April 24, 2012    Clinical Article

7 Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials The Lancet Oncology - Online First, March 22, 2012    Clinical Article

8 Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data Journal of Clinical Oncology, April 5, 2012    Clinical Article

9 Rapid-onset hypogonadism secondary to crizotinib use in men with metastatic nonsmall cell lung cancer Cancer, April 6, 2012    Clinical Article

10 Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial The Lancet Oncology - Online First, March 28, 2012    Clinical Article

11 Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial The Lancet - Early Online Publication, April 5, 2012    Clinical Article

12 The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus International Journal of Cancer, April 26, 2012    Clinical Article

13 Infectious complications of chemotherapy in clinically aggressive mature B and T cell lymphomas European Journal of Internal Medicine , April 3, 2012    Clinical Article

14 Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer JAMA, April 19, 2012    Clinical Article

15 Association between tamoxifen treatment and diabetes Cancer, April 16, 2012    Clinical Article

16 The utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancer International Journal of Cancer, April 23, 2012    Clinical Article

17 Pneumonitis associated with mTOR inhibitors therapy in patients with metastatic renal cell carcinoma: Incidence, radiographic findings and correlation with clinical outcome European Journal of Cancer, April 11, 2012    Clinical Article

18 Digoxin use and the risk of cancers of the corpus uteri, ovary and cervix International Journal of Cancer, April 18, 2012    Clinical Article

19 Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trial The Lancet Oncology - Online First, April 20, 2012    Clinical Article

20 Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C) Journal of Clinical Oncology, April 9, 2012    Clinical Article

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncologymore

Other Topics in Oncology

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Edit My Newsletter Settings

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close